Published by Josh White on 16th February 2018
(ShareCast News) - Next-generation proton therapy systems developer Advanced Oncotherapy announced on Friday that, in relation to its announcement on 7 December and following the passing of the resolution by shareholders on 23 January, it has been informed by Yantai Cipu that the Chinese authorities have authorised the transfer from China of £13.5m.